Reapplix
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
325 Miron Dr Ste 140, Southlake, Texas, ...Phone Number
(877) 629-3443Website
www.reapplix.comRevenue
<$5 MillionIndustry
About Reapplix
Reapplix specializes in personalized wound healing solutions for diabetic foot ulcers through its innovative 3C Patch System. This system creates a single patch using a small sample of the patient's blood, which significantly accelerates the healing process of hard-to-heal wounds. The company targets patients suffering from chronic wounds, particularly those with diabetes, and positions its product as a cost-effective and evidence-based treatment option. Reapplix's technology is recommended by the International Working Group on the Diabetic Foot as an adjunctive treatment.Explore more
Reapplix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Reapplix
Compare insights from companies similar to Reapplix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Reapplix Tech Stack
A closer look at the technologies used by Reapplix
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Reapplix
Sign Up For FreeTo access detailed company insights
Reapplix specializes in personalized wound healing solutions for diabetic foot ulcers through its innovative 3C Patch System. This system creates a single patch using a small sample of the patient's blood, which significantly accelerates the healing process of hard-to-heal wounds. The company targets patients suffering from chronic wounds, particul... Read More
